Last reviewed · How we verify

NCT05557721: USTMS

Uddevalla Skövde Transscleral Micropulse Study

ENROLLING BY INVITATION Last updated 3 December 2024
What this trial tests

trial testing Topical lidocaine in Primary Open Angle Glaucoma in 40 participants. Enrolling by invitation.

Timeline
6 October 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorVastra Gotaland Region
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment40
Start date6 October 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

18 and older, any sex, with Primary Open Angle Glaucoma or Pseudoexfoliation Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Micro pulse transscleral laser treatment (MP-TLT) is a relatively new method to reduce the intraocular pressure (IOP) in glaucoma. New recommendations regarding the treatment protocol has recently been developed and was published 2022. The overall objective is to evaluate the efficacy and safety of the proposed treatment method in an independent study. In addition, the outcome of MP-TLT in patients with pseudoexfoliation glaucoma, which is relatively common in the Nordic countries, and primary open angle glaucoma will be studied separately. The IOP change over the course of one year will be monitored, as well as success rate and survival. Further, patient-reported discomfort from the treatment and the occurrence of any adverse events or complications will be studied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Topical lidocaine

Trials testing the same drug.

Other recruiting trials for Primary Open Angle Glaucoma

Currently open trials in the same condition.

Other Vastra Gotaland Region trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05557721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing